Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

73.3K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
73.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining the role of IgA in a persistent model of Staphylococcus aureus colonization.

PLoS pathogens·2026
Same author

The Role of Dendritic Cells in Adaptive Immune Response Induced by OVA/PDDA Nanoparticles.

Vaccines·2025
Same author

Emerging Cationic Nanovaccines.

Pharmaceutics·2024
Same author

Deficiency in non-classical major histocompatibility class II-like molecule, H2-O confers protection against Staphylococcus aureus in mice.

PLoS pathogens·2024
Same author

Characterization and Differential Cytotoxicity of Gramicidin Nanoparticles Combined with Cationic Polymer or Lipid Bilayer.

Pharmaceutics·2022
Same author

Supramolecular Nanostructures for Vaccines.

Biomimetics (Basel, Switzerland)·2022

Related Experiment Video

Updated: Dec 15, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.9K

Cationic Nanostructures for Vaccines Design.

Ana Maria Carmona-Ribeiro1, Yunys Pérez-Betancourt1

  • 1Biocolloids Laboratory, Instituto de Química, Universidade de São Paulo, Av. Professor Lineu Prestes 748, São Paulo 05508-000, SP, Brazil.

Biomimetics (Basel, Switzerland)
|July 11, 2020
PubMed
Summary
This summary is machine-generated.

This review explores cationic supramolecular assemblies as vaccine adjuvants. These positively charged nanostructures, combined with antigens, show promise for enhancing immune responses, simplifying vaccine design.

Keywords:
biomimetic lipid/polymer nanoparticlescationic adjuvantscationic lipidscationic nanoparticlescationic polymer /biocompatible polymer assembliesdioctadecyldimethylammonium bromidepoly (acrylates)poly cations

More Related Videos

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.0K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K

Related Experiment Videos

Last Updated: Dec 15, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.9K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.0K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K

Area of Science:

  • Vaccine Development
  • Immunology
  • Materials Science

Background:

  • Subunit vaccines require adjuvants to enhance immune responses.
  • Effective vaccine formulations involve antigen carriers, antigens, and immune stimulators (TLRs ligands, inflammasome activators).
  • Antigens are often negatively charged, necessitating complementary positively charged adjuvants.

Purpose of the Study:

  • To review various cationic supramolecular assemblies for their potential as vaccine adjuvants.
  • To explore antigen/adjuvant combinations for optimal in vivo activity, simplicity, and stability.
  • To highlight the importance of positively charged, nanometric, and colloidally stable adjuvant systems.

Main Methods:

  • Discussion of antigen assembled with cationic lipids.
  • Review of antigen assembled with cationic polymers.
  • Analysis of antigen integrated into cationic lipid/polymer and polymer/biocompatible polymer nanostructures.

Main Results:

  • Several cationic assemblies demonstrate potential as general vaccine adjuvants.
  • The combination of antigens with cationic carriers is crucial for adjuvant efficacy.
  • Nanometric size, positive charge, and colloidal stability are key characteristics of effective adjuvants.

Conclusions:

  • Cationic supramolecular assemblies offer promising avenues for advanced vaccine adjuvant design.
  • Further exploration of these positively charged nanostructures is warranted for optimizing vaccine efficacy.
  • Simplicity, stability, and charge are critical factors in developing novel adjuvant systems.